Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9681)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 8, 2015 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Papagianni M, Sofogianni A, Tziomalos K. Non-invasive methods for the diagnosis of nonalcoholic fatty liver disease. World J Hepatol 2015; 7(4): 638-648 [PMID: 25866601 DOI: 10.4254/wjh.v7.i4.638] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i4/638.htm |
| Number | Citing Articles |
| 1 |
Christina N. Katsagoni, Michael Georgoulis, George V. Papatheodoridis, Elisabeth Fragopoulou, Panagiota Ioannidou, Mariviki Papageorgiou, Alexandra Alexopoulou, Nikolaos Papadopoulos, Melanie Deutsch, Meropi D. Kontogianni. Associations Between Lifestyle Characteristics and the Presence of Nonalcoholic Fatty Liver Disease: A Case–Control Study. Metabolic Syndrome and Related Disorders 2017; 15(2): 72 doi: 10.1089/met.2016.0105
|
| 2 |
Shaham Mumtaz, Nathan Schomaker, Natasha Von Roenn. Pro: Noninvasive Imaging Has Replaced Biopsy as the Gold Standard in the Evaluation of Nonalcoholic Fatty Liver Disease. Clinical Liver Disease 2019; 13(4): 111 doi: 10.1002/cld.750
|
| 3 |
Olfa Khalifa, Khaoula Errafii, Nayla S. Al-Akl, Abdelilah Arredouani. Noncoding RNAs in Nonalcoholic Fatty Liver Disease: Potential Diagnosis and Prognosis Biomarkers. Disease Markers 2020; 2020: 1 doi: 10.1155/2020/8822859
|
| 4 |
Kazuma Mori, Marenao Tanaka, Yukimura Higashiura, Nagisa Hanawa, Hirofumi Ohnishi, Masato Furuhashi. High fatty liver index is an independent predictor of ischemic heart disease during a 10‐year period in a Japanese population. Hepatology Research 2022; 52(8): 687 doi: 10.1111/hepr.13790
|
| 5 |
Abdulhakeem S. Alamri, Majid Alhomrani, Walaa F. Alsanie, Ahmad Joman Alghamdi, Zaher M. Alghamdi, Abdualmohsen A. Al-Subaie, Yasser A. Alharthi, Hesham H. Alqurashi, Syed Mohammed Basheeruddin Asdaq. Prevalence and predictors of non-alcoholic fatty liver disease in tertiary care hospital of Taif, Saudi Arabia: A retrospective study. Saudi Journal of Biological Sciences 2021; 28(9): 4921 doi: 10.1016/j.sjbs.2021.05.063
|
| 6 |
Maggie A. Stanislawski, Jessica Shaw, Elizabeth Litkowski, Ethan M. Lange, Wei Perng, Dana Dabelea, Leslie A. Lange. Genetic Risk for Hepatic Fat among an Ethnically Diverse Cohort of Youth: The Exploring Perinatal Outcomes among Children Study. The Journal of Pediatrics 2020; 220: 146 doi: 10.1016/j.jpeds.2020.01.031
|
| 7 |
Yukimura Higashiura, Marenao Tanaka, Kazuma Mori, Takuma Mikami, Itaru Hosaka, Hirofumi Ohnishi, Nagisa Hanawa, Masato Furuhashi, Magnus Bäck. High fibrosis-4 index predicts the new onset of ischaemic heart disease during a 10-year period in a general population. European Heart Journal Open 2022; 2(3) doi: 10.1093/ehjopen/oeac030
|
| 8 |
Yusef M Alenezi, Rebecca Harris , Joanne Morling , Tim Card . Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Saudi Arabia: Systematic Review and Meta-analysis. Cureus 2023; doi: 10.7759/cureus.40308
|
| 9 |
Chayanis Kositamongkol, Thammanard Charernboon, Thanet Chaisathaphol, Chaiwat Washirasaksiri, Chonticha Auesomwang, Tullaya Sitasuwan, Phunchai Charatcharoenwitthaya, Pochamana Phisalprapa. Clinical predictive score for detecting nonalcoholic fatty liver disease with significant fibrosis in patients with metabolic syndrome. Medicine 2021; 100(44): e27640 doi: 10.1097/MD.0000000000027640
|
| 10 |
Bogdan Dzyubak, Jiahui Li, Jie Chen, Kristin C. Mara, Terry M. Therneau, Sudhakar K. Venkatesh, Richard L. Ehman, Alina M. Allen, Meng Yin. Automated Analysis of Multiparametric Magnetic Resonance Imaging/Magnetic Resonance Elastography Exams for Prediction of Nonalcoholic Steatohepatitis. Journal of Magnetic Resonance Imaging 2021; 54(1): 122 doi: 10.1002/jmri.27549
|
| 11 |
Satoko Takahashi, Marenao Tanaka, Masato Furuhashi, Norihito Moniwa, Masayuki Koyama, Yukimura Higashiura, Arata Osanami, Yufu Gocho, Hirofumi Ohnishi, Keita Numata, Takashi Hisasue, Nagisa Hanawa, Tetsuji Miura. Fatty liver index is independently associated with deterioration of renal function during a 10-year period in healthy subjects. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-88025-w
|
| 12 |
Rosanna Villani, Grazia Pia Magnati, Giulia Tuccari, Moris Sangineto, Antonino Davide Romano, Tommaso Cassano, Gaetano Serviddio. Liver fat content assessed by conventional B-mode ultrasound and metabolic profile in non-diabetic patients: Implications for clinical practice. Ultrasound 2023; 31(3): 177 doi: 10.1177/1742271X221122585
|
| 13 |
Paulina Pettinelli, Tiziana Fernández, Carolina Aguirre, Francisco Barrera, Arnoldo Riquelme, Rodrigo Fernández-Verdejo. Prevalence of non-alcoholic fatty liver disease and its association with lifestyle habits in adults in Chile: a cross-sectional study from the National Health Survey 2016–2017. British Journal of Nutrition 2023; 130(6): 1036 doi: 10.1017/S0007114523000028
|
| 14 |
Byoung Seok Ye. Association of nonalcoholic fatty liver disease with incident dementia later in life among elderly adults. Clinical and Molecular Hepatology 2022; 28(3): 481 doi: 10.3350/cmh.2022.0097
|
| 15 |
Qian Li, Manish Dhyani, Joseph R Grajo, Claude Sirlin, Anthony E Samir. Current status of imaging in nonalcoholic fatty liver disease. World Journal of Hepatology 2018; 10(8): 530-542 doi: 10.4254/wjh.v10.i8.530
|
| 16 |
Carla Busquets-Cortés, Miquel Bennasar-Veny, Angel-Arturo López-González, Sergio Fresneda, Antoni Aguiló, Aina Yanez. Fatty liver index and progression to type 2 diabetes: a 5-year longitudinal study in Spanish workers with pre-diabetes. BMJ Open 2021; 11(8): e045498 doi: 10.1136/bmjopen-2020-045498
|
| 17 |
Jae Yeon Lee, Dong Wook Shin, Jeong Won Oh, Won Kim, Sae Kyung Joo, Myung Jae Jeon, Sun Min Kim, Jae Moon Yun, Ki Young Son, Jin Ho Park, Belong Cho, Seung Mi Lee, Silvia C. Sookoian. Non-alcoholic fatty liver disease as a risk factor for female sexual dysfunction in premenopausal women. PLOS ONE 2017; 12(8): e0182708 doi: 10.1371/journal.pone.0182708
|
| 18 |
Per Stål. Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance. World Journal of Gastroenterology 2015; 21(39): 11077-11087 doi: 10.3748/wjg.v21.i39.11077
|
| 19 |
Lawrence Serfaty. Management of patients with non‐alcoholic steatohepatitis (NASH) in real life. Liver International 2018; 38(S1): 52 doi: 10.1111/liv.13637
|
| 20 |
Hossain Salehi, Amir Mohammad Salehi, Mohammad Ebrahim Ghamarchehreh, Elham Khanlarzadeh, Masoud Reza Sohrabi. Diagnostic Accuracy of Vibration Controlled Transient Elastography as Non-invasive Assessment of Liver Fibrosis in Patients with Non-alcoholic Fatty Liver Disease. Middle East Journal of Digestive Diseases 2023; 15(1): 26 doi: 10.34172/mejdd.2023.316
|
| 21 |
Jieun Chung, Hee-Sun Park, Young-Jun Kim, Mi-Hye Yu, Sungeun Park, Sung-Il Jung. Association of Hepatic Steatosis Index with Nonalcoholic Fatty Liver Disease Diagnosed by Non-Enhanced CT in a Screening Population. Diagnostics 2021; 11(12): 2168 doi: 10.3390/diagnostics11122168
|
| 22 |
Juana Carretero Gómez, Javier Ena, José Miguel Seguí Ripoll, Francisco Javier Carrasco-Sánchez, Ricardo Gómez Huelgas, José Manuel Casas Rojo, Manuel Suárez Tembra, Juan Jesús Carabantes Rueda, José Carlos Arévalo Lorido. Effect of newer antihyperglycemic drugs on liver steatosis indices in patients with diabetes and obesity. Current Medical Research and Opinion 2021; 37(11): 1867 doi: 10.1080/03007995.2021.1965563
|
| 23 |
Sergio Fresneda, Manuela Abbate, Carla Busquets-Cortés, Arturo López-González, Pilar Fuster-Parra, Miquel Bennasar-Veny, Aina M. Yáñez. Sex and age differences in the association of fatty liver index-defined non-alcoholic fatty liver disease with cardiometabolic risk factors: a cross-sectional study. Biology of Sex Differences 2022; 13(1) doi: 10.1186/s13293-022-00475-7
|
| 24 |
Jamak Modaresi Esfeh, Kianoush Ansari-Gilani. Steatosis and hepatitis C. Gastroenterology Report 2015; : gov040 doi: 10.1093/gastro/gov040
|
| 25 |
Tae‐Hoon Kim, Hong Young Jun, Ki‐Jong Kim, Young Hwan Lee, Myeung Su Lee, Keum Ha Choi, Ki Jung Yun, Yong Yeon Jeong, Chung Hwan Jun, Eun Young Cho, Kwon‐Ha Yoon. Hepatic Alanine Differentiates Nonalcoholic Steatohepatitis From Simple Steatosis in Humans and Mice: A Proton MR Spectroscopy Study With Long Echo Time. Journal of Magnetic Resonance Imaging 2017; 46(5): 1298 doi: 10.1002/jmri.25673
|
| 26 |
Djuro Macut, Ivana Božić-Antić, Jelica Bjekić-Macut, Konstantinos Tziomalos. MANAGEMENT OF ENDOCRINE DISEASE: Polycystic ovary syndrome and nonalcoholic fatty liver disease. European Journal of Endocrinology 2017; 177(3): R145 doi: 10.1530/EJE-16-1063
|
| 27 |
Alexandra Wuopio, Brett M. Baker, Benjamin Koethe, Martin D. Goodman, Reuben Shin, Nikolay Bugaev, Dmitry Nepomnayshy, Woon Cho Kim, Thomas Schnelldorfer. Can Surgeons Reliably Identify Non-cirrhotic Liver Disease During Laparoscopic Bariatric Surgery?. Obesity Surgery 2024; 34(3): 769 doi: 10.1007/s11695-024-07070-2
|
| 28 |
Sheng Wang, Jian-Qing Wang, Xiong-Wen Lv. Exosomal miRNAs as biomarkers in the diagnosis of liver disease. Biomarkers in Medicine 2017; 11(6): 491 doi: 10.2217/bmm-2017-0011
|
| 29 |
Surasak Saokaew, Chayanis Kositamongkol, Phunchai Charatcharoenwitthaya, Weerachai Srivanichakorn, Chaiwat Washirasaksiri, Nathorn Chaiyakunapruk, Pochamana Phisalprapa. Comparison of noninvasive scoring systems for the prediction of nonalcoholic fatty liver disease in metabolic syndrome patients. Medicine 2020; 99(50): e23619 doi: 10.1097/MD.0000000000023619
|
| 30 |
Limei Li, Yan Song, Yongquan Shi, Liangliang Sun. Thyroid Hormone Receptor-β Agonists in NAFLD Therapy: Possibilities and Challenges. The Journal of Clinical Endocrinology & Metabolism 2023; 108(7): 1602 doi: 10.1210/clinem/dgad072
|
| 31 |
Anugayathri Jawahar, Beverly Gonzalez, Neelam Balasubramanian, William Adams, Ari Goldberg. Comparison of computed tomography hepatic steatosis criteria for identification of abnormal liver function and clinical risk factors, in incidentally noted fatty liver. European Journal of Gastroenterology & Hepatology 2020; 32(2): 216 doi: 10.1097/MEG.0000000000001502
|
| 32 |
Nancy de los Ángeles Segura-Azuara, Carlos Daniel Varela-Chinchilla, Plinio A. Trinidad-Calderón. MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis. Frontiers in Medicine 2022; 8 doi: 10.3389/fmed.2021.774079
|
| 33 |
Josep Franch-Nadal, Llorenç Caballeria, Manel Mata-Cases, Didac Mauricio, Carolina Giraldez-García, José Mancera, Albert Goday, Xavier Mundet-Tudurí, Enrique Regidor, Yu Wang. Fatty liver index is a predictor of incident diabetes in patients with prediabetes: The PREDAPS study. PLOS ONE 2018; 13(6): e0198327 doi: 10.1371/journal.pone.0198327
|
| 34 |
Marta Iruarrizaga-Lejarreta, Fernando Bril, Mazen Noureddin, Pablo Ortiz, Shelly C. Lu, José M. Mato, Cristina Alonso. Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease. 2019; : 423 doi: 10.1007/978-3-030-11748-1_16
|
| 35 |
Haruka Hirono, Kazuhiko Watanabe, Katsuhiko Hasegawa, Shogo Ohkoshi. Practical Use of Transient Elastography in Screening for Nonalcoholic Steatohepatitis in a Japanese Population. Journal of Clinical and Translational Hepatology 2019; 7(2): 1 doi: 10.14218/JCTH.2018.00048
|
| 36 |
Zhilu Xu, Xiang Zhang, Jennie Lau, Jun Yu. C-X-C motif chemokine 10 in non-alcoholic steatohepatitis: role as a pro-inflammatory factor and clinical implication. Expert Reviews in Molecular Medicine 2016; 18 doi: 10.1017/erm.2016.16
|
| 37 |
L. A. Strashok, O. V. Buznytska. Experience of using static hepatoscintigraphy to assess the functional state of the liver in adolescents with metabolic syndrome. Problems of Uninterrupted Medical Training and Science 2019; 2019(2): 18 doi: 10.31071/promedosvity2019.02.018
|
| 38 |
Na Di, Xinchuan Zhou, Yaxiao Chen, Xiaomiao Zhao, Lin Li, Linlin Jiang, Baoming Luo, Xiaoli Chen, Dongzi Yang. Could semiquantitative analysis of real-time ultrasound elastography distinguish more liver parenchyma alterations of nonalcoholic fatty liver disease in patients with polycystic ovary syndrome?. Archives of Endocrinology and Metabolism 2019; doi: 10.20945/2359-3997000000119
|
| 39 |
Jaskamal Padda, Khizer Khalid, Anwar Khedr, Fahriba Tasnim, Ola A Al-Ewaidat, Ayden Charlene Cooper, Gutteridge Jean-Charles. Non-Alcoholic Fatty Liver Disease and Its Association With Diabetes Mellitus. Cureus 2021; doi: 10.7759/cureus.17321
|
| 40 |
O. V. Buznytska. Diagnostic significance of biochemical indicators of liver fibrogenesis in adolescents with obesity. The Ukrainian Biochemical Journal 2019; 91(1): 74 doi: 10.15407/ubj91.01.074
|
| 41 |
Judith Aron-Wisnewsky, Chloé Vigliotti, Julia Witjes, Phuong Le, Adriaan G. Holleboom, Joanne Verheij, Max Nieuwdorp, Karine Clément. Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders. Nature Reviews Gastroenterology & Hepatology 2020; 17(5): 279 doi: 10.1038/s41575-020-0269-9
|
| 42 |
D. Macut, K. Tziomalos, I. Božić-Antić, J. Bjekić-Macut, I. Katsikis, E. Papadakis, Z. Andrić, D. Panidis. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome. Human Reproduction 2016; 31(6): 1347 doi: 10.1093/humrep/dew076
|
| 43 |
Yukimura Higashiura, Masato Furuhashi, Marenao Tanaka, Satoko Takahashi, Masayuki Koyama, Hirofumi Ohnishi, Keita Numata, Takashi Hisasue, Nagisa Hanawa, Norihito Moniwa, Kazufumi Tsuchihashi, Tetsuji Miura. High level of fatty liver index predicts new onset of diabetes mellitus during a 10-year period in healthy subjects. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-92292-y
|
| 44 |
A Lum Han. Association between Non-Alcoholic Fatty Liver Disease and Dietary Habits, Stress, and Health-Related Quality of Life in Korean Adults. Nutrients 2020; 12(6): 1555 doi: 10.3390/nu12061555
|
| 45 |
Anugayathri Jawahar, Beverly Gonzalez, Neelam Balasubramanian, William Adams, Ari Goldberg. Comparison of correlations between lipid profile and different computed tomography fatty liver criteria in the setting of incidentally noted fatty liver on computed tomography examinations. European Journal of Gastroenterology & Hepatology 2017; 29(12): 1389 doi: 10.1097/MEG.0000000000000972
|
| 46 |
Fernando Bril, Kenneth Cusi. Nonalcoholic Fatty Liver Disease. Endocrinology and Metabolism Clinics of North America 2016; 45(4): 765 doi: 10.1016/j.ecl.2016.06.005
|
| 47 |
Mahdi Barazesh, Sajad Jalili, Morteza Akhzari, Fouzieyeh Faraji, Ebrahim Khorramdin. Recent Progresses on Pathophysiology, Diagnosis, Therapeutic Modalities,
and Management of Non-alcoholic Fatty Liver Disorder. Current Drug Therapy 2024; 19(1): 20 doi: 10.2174/1574885518666230417111247
|
| 48 |
Alessandro Ciresi, Valentina Guarnotta, Daniela Campo, Carla Giordano. Hepatic Steatosis Index in Acromegaly: Correlation with Insulin Resistance Regardless of the Disease Control. International Journal of Endocrinology 2018; 2018: 1 doi: 10.1155/2018/5421961
|
| 49 |
Yukimura Higashiura, Masato Furuhashi, Marenao Tanaka, Satoko Takahashi, Kazuma Mori, Daisuke Miyamori, Masayuki Koyama, Hirofumi Ohnishi, Norihito Moniwa, Keita Numata, Takashi Hisasue, Nagisa Hanawa, Tetsuji Miura. Elevated Fatty Liver Index Is Independently Associated With New Onset of Hypertension During a 10‐Year Period in Both Male and Female Subjects. Journal of the American Heart Association 2021; 10(14) doi: 10.1161/JAHA.121.021430
|
| 50 |
Alba Otoni, Carlos Mauricio de Figueiredo Antunes, Fernanda Ferreira Tavares, Débora Heloísa Quadros Araújo, Thiago de Almeida Pereira, Leonardo Campos de Queiroz, Frederico Figueiredo Amâncio, José Roberto Lambertucci. Thrombocytopenia as a marker of liver steatosis in a low-endemic area for schistosomiasis mansoni. Revista da Associação Médica Brasileira 2017; 63(6): 532 doi: 10.1590/1806-9282.63.06.532
|
| 51 |
J. Caudet, M. Trelis, S. Cifre, J. M. Soriano, J. F. Merino-Torres. Presence and significance of intestinal unicellular parasites in a morbidly obese population. International Journal of Obesity 2022; 46(1): 220 doi: 10.1038/s41366-021-00980-6
|
| 52 |
Minakshi Rana, Manisha Saini, Rina Das, Sumeet Gupta, Tanishq Joshi, Dinesh Kumar Mehta. Circulating MicroRNAs: Diagnostic Value as Biomarkers in the Detection
of Non-alcoholic Fatty Liver Diseases and Hepatocellular Carcinoma. MicroRNA 2023; 12(2): 99 doi: 10.2174/2211536612666230330083146
|
| 53 |
Masato Furuhashi, Yu Kataoka, Ryo Nishikawa, Masayuki Koyama, Akiko Sakai, Yukimura Higashiura, Marenao Tanaka, Shigeyuki Saitoh, Kazuaki Shimamoto, Hirofumi Ohnishi. Circulating PCSK7 Level is Independently Associated with Obesity, Triglycerides Level and Fatty Liver Index in a General Population without Medication. Journal of Atherosclerosis and Thrombosis 2022; 29(9): 1275 doi: 10.5551/jat.63159
|
| 54 |
Poor Performance of Non-invasive Tests for Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: A Multicentric Asian Study. Digestive Diseases and Sciences 2023; 68(12): 4485 doi: 10.1007/s10620-023-08085-y
|
| 55 |
İsa Çam, Ural Koc, Samet Genez, Abdullah Güneş. Computed Tomography Measurements of Hepatic Steatosis in Cholelitihiasis and Cholecystectomy Cases Using Unenhanced Images. Journal of Medical Imaging and Radiation Sciences 2020; 51(1): 137 doi: 10.1016/j.jmir.2019.12.003
|
| 56 |
Maria Pokorska-Śpiewak, Barbara Kowalik-Mikołajewska, Małgorzata Aniszewska, Magdalena Pluta, Magdalena Marczyńska. Novel serum biomarkers modified by the body mass index z-score for the detection of liver fibrosis and steatosis in children with chronic hepatitis C. BMC Infectious Diseases 2017; 17(1) doi: 10.1186/s12879-017-2462-1
|
| 57 |
Stefania Di Mauro, Alessandra Scamporrino, Salvatore Petta, Francesca Urbano, Agnese Filippello, Marco Ragusa, Maria T. Di Martino, Francesca Scionti, Stefania Grimaudo, Rosaria M. Pipitone, Graziella Privitera, Antonino Di Pino, Roberto Scicali, Luca Valenti, Paola Dongiovanni, Anna Fracanzani, Agata M. Rabuazzo, Antonio Craxì, Michele Purrello, Francesco Purrello, Salvatore Piro. Serum coding and non‐coding RNAs as biomarkers of NAFLD and fibrosis severity. Liver International 2019; 39(9): 1742 doi: 10.1111/liv.14167
|
| 58 |
Kenneth Cusi. Diabetes and Exercise. Contemporary Diabetes 2018; : 47 doi: 10.1007/978-3-319-61013-9_4
|
| 59 |
Tae-In Hwang, A-Lum Han. Quality of Life in Adults with Metabolic Dysfunction-Associated Fatty Liver Disease. International Journal of Environmental Research and Public Health 2021; 18(24): 13145 doi: 10.3390/ijerph182413145
|
| 60 |
Chunfang Xu, Zhenguo Qiao, Yongda Lu, Deqing Zhang, Zhenyu Jia, Xiaohui Zhuang, Yuqi Shi, Ting Xu, Lihua Xing, Jiaqing Shen, Zoltán Rakonczay. Influence of Fatty Liver on the Severity and Clinical Outcome in Acute Pancreatitis. PLOS ONE 2015; 10(11): e0142278 doi: 10.1371/journal.pone.0142278
|
| 61 |
Zoran Gluvic, Ratko Tomasevic, Ksenija Bojovic, Milan Obradovic, Esma R. Isenovic. Non-alcoholic fatty liver disease: a multidisciplinary clinical practice approach—the institutional adaptation to existing Clinical Practice Guidelines. Emergency and Critical Care Medicine 2022; 2(1): 12 doi: 10.1097/EC9.0000000000000016
|
| 62 |
Jeongmin Lee, Jeonghoon Ha, Kwanhoon Jo, Dong-Jun Lim, Jung-Min Lee, Sang-Ah Chang, Moo-Il Kang, Bong-Yun Cha, Min-Hee Kim. Male-specific association between subclinical hypothyroidism and the risk of non-alcoholic fatty liver disease estimated by hepatic steatosis index: Korea National Health and Nutrition Examination Survey 2013 to 2015. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-32245-0
|
| 63 |
Parambir S. Dulai, Claude B. Sirlin, Rohit Loomba. MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice. Journal of Hepatology 2016; 65(5): 1006 doi: 10.1016/j.jhep.2016.06.005
|